Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?

Title
Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?
Authors
Keywords
Bioanalytical method validation, Pharmacokinetics, Toxicokinetics, Regulated bioanalysis, Food and Drug Administration
Journal
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Volume 165, Issue -, Pages 381-385
Publisher
Elsevier BV
Online
2018-12-20
DOI
10.1016/j.jpba.2018.12.030

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now